Government Reseller Pathways Leverage existing SofPulse distribution with Academy Medical and target additional SDVOSB resellers, VA hospitals, and DoD medical centers through federal procurement channels. Emphasize non-invasive, opioid-reduction and post-op recovery benefits; provide clinical data and success stories to procurement teams; build a multi-distributor strategy to scale revenues.

Academic Collaboration Expand on Stanford collaboration with new clinical studies in orthopedics, pain management, and inflammation to strengthen evidence for SofPulse and Cytotronics. Develop joint grant proposals and hospital-based pilots; offer licensing or sponsored trials to universities to accelerate market-ready data and create credible case studies.

Global Market Expansion Pursue international SofPulse rollout as part of the Go-To-Market initiative. Identify regulatory and reimbursement pathways, recruit regional distributors, and provide comprehensive training and service commitments to ensure market readiness in target regions.

Platform Licensing Explore B2B partnerships for Cytotronics and Immunotronics with biotech labs and tissue-engineering firms. Consider licensing, co-development agreements, or contract research to monetize platform capabilities while building a customer base in regenerative medicine.

Pain Management Focus Position SofPulse as a non-opioid adjunct for postoperative and chronic pain management. Target hospitals, ambulatory surgical centers, pain clinics, and public health programs; align with payer incentives and opioid reduction goals; provide ROI case studies to accelerate procurement decisions.